Vimarsana
Biggest News Aggregation in the World

Stephen Lamond News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stephen Lamond. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stephen Lamond Today - Breaking & Trending Today

Peak Bio, Inc. Announces Filing of Provisional Patent Applications for PH-1, a Novel and Specific Immunomodulatory ADC payload platform targeting RNA splicing - Vimarsana News

Peak Bio, Inc. Announces Filing of Provisional Patent Applications for PH-1, a Novel and Specific Immunomodulatory ADC payload platform targeting RNA splicing

Published: September 19, 2023

Pleasanton, CA, Sept. 19, 2023 -- Peak Bio, Inc. , is a clinical-stage biopharmaceutical company focused on developing and commercializing the next-generation of innovative therapeutics that aim...

Source: marketscreener.com
Related Topics:
United StatesStephen LamondTrademark OfficeExchange CommissionPeak Bio IncUnited States PatentPeak BioPrivate Securities Litigation Reform ActRegistration StatementAnnual Report
Peak Bio, Inc., Announces Appointment of Michael Friedman to Board of Directors -Today at 08:03 am - Vimarsana News

Peak Bio, Inc., Announces Appointment of Michael Friedman to Board of Directors -Today at 08:03 am

Published: August 31, 2023

Pleasanton, CA, Aug. 31, 2023 -- Peak Bio, Inc. , is a clinical-stage biopharmaceutical company focused on developing the next-generation of therapeutics to treat oncology and inflammatory...

Source: marketscreener.com
Related Topics:
America Merrill LynchStephen LamondHoyoung HuhMichael FriedmanPeak Bio IncLadenburg Thalmann CoCompensation CommitteeCompany Board Of DirectorsBooth School Of BusinessCompany Audit CommitteeExchange CommissionUniversity Of ChicagoUniversity Of WisconsinAudit CommitteeSenior Vice PresidentLadenburg ThalmannHealthcare Investment BankingBooth SchoolPeak BioPrivate Securities Litigation Reform ActRegistration StatementAnnual Report
Peak Bio, Inc. Announces Up-listing to OTCQB Market -Today at 09:36 am - Vimarsana News

Peak Bio, Inc. Announces Up-listing to OTCQB Market -Today at 09:36 am

Published: August 31, 2023

Pleasanton, CA, Aug. 31, 2023 -- Peak Bio, Inc. , is a clinical-stage biopharmaceutical company focused on developing and commercializing the next-generation of innovative therapeutics that aim to...

Source: marketscreener.com
Related Topics:
United StatesStephen LamondExchange CommissionPeak Bio IncGroup IncVenture MarketPeak BioHarbor StatementPrivate Securities Litigation Reform ActRegistration StatementAnnual Report
Peak Bio, Inc. Announces Amendment and Continued Access to Equity Line of up to $100 Million USD via an Accelerated Common Stock Purchase Transaction with White Lion Capital - Vimarsana News

Peak Bio, Inc. Announces Amendment and Continued Access to Equity Line of up to $100 Million USD via an Accelerated Common Stock Purchase Transaction with White Lion Capital

Published: August 24, 2023

Pleasanton, CA, Aug. 24, 2023 -- Peak Bio, Inc. , is a clinical-stage biopharmaceutical company focused on developing and commercializing the next-generation of innovative therapeutics that aim to...

Source: marketscreener.com
Related Topics:
Stephen LamondExchange CommissionWhite Lion CapitalPeak Bio IncCommon Stock Purchase AgreementWhite LionPeak BioPrivate Securities Litigation Reform ActRegistration StatementAnnual Report
Peak Bio, Inc. Presents Preclinical Data Highlighting Potential of Differentiated Trop2 PH1 (Novel Payload) ADC in Poster at 2023 AACR Annual Meeting - Vimarsana News

Peak Bio, Inc. Presents Preclinical Data Highlighting Potential of Differentiated Trop2 PH1 (Novel Payload) ADC in Poster at 2023 AACR Annual Meeting

Published: August 23, 2023

Pleasanton, CA, Aug. 23, 2023 -- Peak Bio, Inc. , is a clinical-stage biopharmaceutical company focused on developing the next-generation of therapeutics to treat oncology and inflammatory...

Source: marketscreener.com
Related Topics:
Stephen LamondExchange CommissionGlobenewswire IncPeak Bio IncPeak BioMolecular TherapeuticsGrowth Factor ReceptorsTherapeutic TargetsPrivate Securities Litigation Reform ActRegistration StatementAnnual Report